Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

WARRANTS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended		6 Months Ended
	Mar. 06, 2024	Jun. 01, 2023	Jul. 28, 2020	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Oct. 16, 2020	Jan. 26, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number				370,025		370,025
Debt face amount				$ 10,820		$ 10,820		$ 16,304
Share-based Payment Arrangement, Tranche One [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt face amount			$ 20,000
CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares										33,334
Exercise price of warrants										$ 396
Investment Agreement [Member] \| CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares				50,207		50,207
Exercise price of warrants				$ 283.81		$ 283.81
Weighted average remaining life of warrants						1 year 1 month 9 days
Warrant expire date				Jan. 26, 2025		Jan. 26, 2025
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised	142,857	194,444	2,873
Exercise price of warrants			$ 208.8
Loan Agreement [Member] \| K2 Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised			2,873
Warrants outstanding to purchase of common stock shares			2,873
Exercise price of warrants			$ 208.8
Warrant expire date			Jul. 28, 2030
Professional Services Agreement [Member] \| Warrants [Member] \| Investor Relations Service Provider [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares									14,000
Exercise price of warrants									$ 32.1
Warrant expire date									Nov. 03, 2025
Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised				0	0	0	0